Product Information
POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by Strides Pharma Inc., priced at $0.1796 per EA under NDC 42543040801. Its NADAC has been published 458 times since Sep 27, 2017.
Strength
15 meq/1
Manufacturer
Strides Pharma Inc.NDC
42543040801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206813On Market Since
11/1/2017
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 458 times since Sep 27, 2017, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1796 per EA |
|---|---|
| All-time high | $1.8437 (Mar 14, 2018) |
| All-time low | $0.1722 (Jul 17, 2024) |
| 52-week high | $0.2203 |
| 52-week low | $0.1796 |
| Median price | $0.7099 |
| Average price | $0.7867 |
| Largest weekly change | +69.2% (May 17, 2023) |
| Weeks tracked | 458 |
| Tracking since | Sep 27, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the POTASSIUM CITRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by Strides Pharma Inc., is $0.1796 per EA (NDC 42543040801), effective Jul 1, 2026.
How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 90.2%. It has been tracked across 458 weekly CMS publications since Sep 27, 2017.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?
Since Sep 27, 2017, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $1.8437 (Mar 14, 2018), with a median of $0.7099 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CITRATE ER 15 MEQ TB, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?
POTASSIUM CITRATE ER 15 MEQ TB (NDC 42543040801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification